Carlos A Barrero
Overview
Explore the profile of Carlos A Barrero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
584
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang F, Barrero C
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456887
Despite recent advances in chronic obstructive pulmonary disease (COPD) research, few studies have identified the potential therapeutic targets systematically by integrating multiple-omics datasets. This project aimed to develop a systems...
2.
Merali C, Quinn C, Huffman K, Pieper C, Bogan J, Barrero C, et al.
Obesity (Silver Spring)
. 2024 Oct;
32(12):2286-2298.
PMID: 39420421
Objective: Caloric restriction (CR) is known to enhance insulin sensitivity and reduce the risk of metabolic disorders; however, its molecular mechanisms are not fully understood. This study aims to elucidate...
3.
Rico M, Perez-Leal O, Barbe M, Amin M, Colussi D, Florez M, et al.
Biomolecules
. 2023 Sep;
13(9).
PMID: 37759735
Extracellular histones, part of the protein group known as damage-associated molecular patterns (DAMPs), are released from damaged or dying cells and can instigate cellular toxicity. Within the context of chronic...
4.
Quinn C, Rico M, Merali C, Barrero C, Perez-Leal O, Mischley V, et al.
Sci Transl Med
. 2023 Sep;
15(715):eade2966.
PMID: 37756380
Hepatic fibrosis is the primary determinant of mortality in patients with metabolic dysfunction-associated steatohepatitis (MASH). Transforming growth factor-β (TGFβ), a master profibrogenic cytokine, is a promising therapeutic target that has...
5.
Li J, Arest S, Olszowy B, Gordon J, Barrero C, Perez-Leal O
Antioxidants (Basel)
. 2023 Jul;
12(7).
PMID: 37507903
With the rising prevalence of obesity, non-alcoholic fatty liver disease (NAFLD) now affects 20-25% of the global population. NAFLD, a progressive condition associated with oxidative stress, can result in cirrhosis...
6.
Afifi N, Barrero C
J Clin Med
. 2023 Feb;
12(4).
PMID: 36835911
Breast cancer (BC) is the most common form of cancer in women worldwide [...].
7.
Khachatryan H, Olszowy B, Barrero C, Gordon J, Perez-Leal O
Biomolecules
. 2023 Feb;
13(2).
PMID: 36830618
Tubulin is a protein that plays a critical role in maintaining cellular structure and facilitating cell division. Inhibiting tubulin polymerization has been shown to be an effective strategy for inhibiting...
8.
Prabha S, Merali C, Sehgal D, Nicolas E, Bhaskar N, Flores M, et al.
Mater Today Bio
. 2023 Feb;
19:100567.
PMID: 36747581
Engineered mesenchymal stem cells (MSCs) have been investigated extensively for gene delivery and, more recently, for targeted small molecule delivery. While preclinical studies demonstrate the potential of MSCs for targeted...
9.
Chen X, Barrero C, Vasquez-Del Carpio R, Reddy E, Fecchio C, Merali S, et al.
Pharmaceutics
. 2021 Dec;
13(12).
PMID: 34959389
Posiphen tartrate (Posiphen) is an orally available small molecule that targets a conserved regulatory element in the mRNAs of amyloid precursor protein (APP) and α-synuclein (αSYN) and inhibits their translation....
10.
Perez-Leal O, Nixon-Abell J, Barrero C, Gordon J, Oesterling J, Rico M
CRISPR J
. 2021 Dec;
4(6):854-871.
PMID: 34847745
The lack of efficient tools to label multiple endogenous targets in cell lines without staining or fixation has limited our ability to track physiological and pathological changes in cells over...